TAZTIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Taztia, and what generic alternatives are available?
Taztia is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.
The generic ingredient in TAZTIA is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Taztia
A generic version of TAZTIA was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TAZTIA?
- What are the global sales for TAZTIA?
- What is Average Wholesale Price for TAZTIA?
Summary for TAZTIA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TAZTIA at DailyMed |
US Patents and Regulatory Information for TAZTIA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-001 | Apr 10, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-004 | Apr 10, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-002 | Apr 10, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-003 | Apr 10, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Labs Fl Inc | TAZTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 075401-005 | Apr 10, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
